Cefuroxime

Cefuroxime Struktur
55268-75-2
CAS-Nr.
55268-75-2
Englisch Name:
Cefuroxime
Synonyma:
CEFUROXIME AXETIL;Cefuroxime acid;cefuroxim;Cephuroxime;Cefuroxime VETRANAL;Cefuroxime Axetil EP Impurity D;-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid;CXM;-7-((Z);Ketocef
CBNumber:
CB7707485
Summenformel:
C16H16N4O8S
Molgewicht:
424.39
MOL-Datei:
55268-75-2.mol

Cefuroxime Eigenschaften

Schmelzpunkt:
171.5-173°C
alpha 
D20 +63.7° (c = 1.0 in 0.2M pH 7 phosphate buffer)
Dichte
1.76
Brechungsindex
1.6000 (estimate)
storage temp. 
2-8°C
Löslichkeit
DMSO (Slightly), Methanol (Slightly)
pka
pKa 2.5(H2O) (Uncertain)
Aggregatzustand
Solid
Farbe
White to Off-White
Wasserlöslichkeit
145mg/L at 25℃
BCS Class
4
Major Application
clinical testing
InChIKey
JFPVXVDWJQMJEE-IZRZKJBUSA-N
SMILES
N12[C@@]([H])([C@H](NC(/C(/C3=CC=CO3)=N\OC)=O)C1=O)SCC(COC(N)=O)=C2C(O)=O
CAS Datenbank
55268-75-2(CAS DataBase Reference)
EPA chemische Informationen
5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 3-[[(aminocarbonyl)oxy]methyl]-7-[[(2Z)-2-(2-furanyl)-2-(methoxyimino)acetyl]amino]-8-oxo-, (6R,7R)- (55268-75-2)
Sicherheit
  • Risiko- und Sicherheitserklärung
  • Gefahreninformationscode (GHS)
Kennzeichnung gefährlicher Xn
R-Sätze: 42/43
S-Sätze: 22-24-37-45
WGK Germany  3
RTECS-Nr. XI0329000
Speicherklasse 11 - Combustible Solids
Bildanzeige (GHS) Health Hazard (GHS08)
Alarmwort Achtung
Gefahrenhinweise
Code Gefahrenhinweise Gefahrenklasse Abteilung Alarmwort Symbol P-Code
H317 Kann allergische Hautreaktionen verursachen. Sensibilisierung der Haut Kategorie 1A Warnung P261, P272, P280, P302+P352,P333+P313, P321, P363, P501
H334 Kann bei Einatmen Allergie, asthmaartige Symptome oder Atembeschwerden verursachen. Sensibilisierung der Atemwege Kategorie 1 Achtung P261, P285, P304+P341, P342+P311,P501
Sicherheit
P261 Einatmen von Staub vermeiden.
P272 Kontaminierte Arbeitskleidung nicht außerhalb des Arbeitsplatzes tragen.
P280 Schutzhandschuhe/Schutzkleidung/Augenschutz tragen.
P285 Bei unzureichender Belüftung Atemschutz tragen.
P302+P352 BEI BERÜHRUNG MIT DER HAUT: Mit viel Wasser/... (Hersteller kann, falls zweckmäßig, ein Reinigungsmittel angeben oder, wenn Wasser eindeutig ungeeignet ist, ein alternatives Mittel empfehlen) waschen.
P304+P341 BEI EINATMEN: Bei Atembeschwerden an die frische Luft bringen und in einer Position ruhigstellen, die das Atmen erleichtert
P321 Besondere Behandlung
P333+P313 Bei Hautreizung oder -ausschlag: Ärztlichen Rat einholen/ärztliche Hilfe hinzuziehen.
P342+P311 Bei Symptomen der Atemwege: GIFTINFORMATIONSZENTRUM/Arzt/... (geeignete Stelle für medizinische Notfallversorgung vom Hersteller/Lieferanten anzugeben) anrufen.
P363 Kontaminierte Kleidung vor erneutem Tragen waschen.
P501 Inhalt/Behälter ... (Entsorgungsvorschriften vom Hersteller anzugeben) zuführen.

Cefuroxime Chemische Eigenschaften,Einsatz,Produktion Methoden

R-Sätze Betriebsanweisung:

R42/43:Sensibilisierung durch Einatmen und Hautkontakt möglich.

S-Sätze Betriebsanweisung:

S22:Staub nicht einatmen.
S24:Berührung mit der Haut vermeiden.
S37:Geeignete Schutzhandschuhe tragen.
S45:Bei Unfall oder Unwohlsein sofort Arzt zuziehen (wenn möglich, dieses Etikett vorzeigen).

Beschreibung

Cefuroxime axetil is the acetoxyethyl ester and oral prodrug of cefuroxime, a second-generation cephalosporin. It has a broad spectrum of action and is resistant to most P-lactamases. Cefuroxime axed is indicated for serious bacterial infections, especially where no identification of organism(s) has been made.

Chemische Eigenschaften

white crystalline solid

Verwenden

Cefuroxime is a second-generation cephalosporin antibiotic.

Application

Cefuroxime was synthesized by Glaxo Laboratories in 1975 as the first cephem antibiotic with the methoxyimino group at the 7 position. It is highly resistant to hydrolysis by cephalosporinase and is active against a variety of gram-negative bacteria, including indolepositive Proteus, Enterobacter, and Citrobacter. Cefuroxime is considered to be one of the socalled second-generation cephalosporins.

Definition

ChEBI: A 3-(carbamoyloxymethyl)cephalosporin compound having a 7-(2Z)-2-(furan-2-yl)-2-(methoxyimino)acetamido side chain.

Antimicrobial activity

The methoximino side chain provides stability to most Gram-negative β-lactamases and it is active against most enterobacteria, including many multiresistant strains. Acinetobacter spp., S. marcescens and Ps. aeruginosa are resistant, although some Burkholderia cepacia strains are susceptible. Some anaerobic Gram-negative rods are susceptible, but B. fragilis is resistant. The minimum immobilizing concentration for the Nichol’s strain of T. pallidum is 0.01 mg/L.

Pharmakologie

Cefuroxime acts bactericidally. It has a narrow spectrum of antimicrobial action. It is resistant to beta-lactamase action. It is highly active with respect to Gram-negative microorganisms (intestinal and hemophilial bacilli, salmonella, shigella, enterobacteria, and gonococci). It is also active with respect to Gram-positive microorganisms (staphylococci, streptococci). It is inactive with respect to various types of Pseudomonas, most strains of enterococci, many strains of Enterobacter cloacae, methylcillin-resistant staphylococci, and L. monocytogenes.
It is used for bacterial infections caused by microorganisms that are sensitive to the drug. These may be abdominal and gynecological infections, sepsis, meningitis, endocarditis, infections of the urinary and respiratory tracts, bones, joints, skin, and soft tissues. It is widely used for pneumonia as well as bacterial meningitis in children, and for post-operational infectious complications. Synonyms of this drug are ceftin, zinacef, curoxim, kefox, and many others.

Clinical Use

Cefuroxime axetil (Ceftin) is the 1-acetyoxyethyl ester ofcefuroxime. During absorption, this acid-stable, lipophilic,oral prodrug derivative of cefuroxime is hydrolyzed to cefuroximeby intestinal and/or plasma enzymes. The axetilester provides an oral bioavailability of 35% to 50% of cefuroxime,depending on conditions. Oral absorption of theester is increased by food but decreased by antacids and histamineH2-antagonists. The latter effect may be because ofspontaneous hydrolysis of the ester in the intestine becauseof the higher pH created by these drugs. Axetil is used forthe oral treatment of non–life-threatening infections causedby bacteria that are susceptible to cefuroxime. The prodrugform permits twice-a-day dosing for such infections.

Nebenwirkungen

It is well tolerated with little pain or phlebitis on injection. Minor hypersensitivity reactions and biochemical changes common to cephalosporins are described.
The axetil ester may cause diarrhea and, in some cases, vomiting. Changes in the bowel flora, sometimes with the appearance of C. difficile, have been reported in about 15% of patients. Vaginitis is reported in about 2% of female patients.

Cefuroxime Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


Cefuroxime Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 297)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Beijing PUXI Technology Co., Ltd 400-808-7372 13161114455
1718638899@qq.com China 4994 58
J & K SCIENTIFIC LTD. 18210857532 18210857532
jkinfo@jkchemical.com China 96815 76
Chembest Research Laboratories Limited 021-20908456
sales@BioChemBest.com China 5996 61
TAIYUAN RHF CO.,LTD. +86 351 7031519
sales@RHFChem.com China 2334 56
Pure Chemistry Scientific Inc. 001-857-928-2050 or 1-888-588-9418
sales@chemreagents.com United States 10174 62
Adamas Reagent, Ltd. 4006009262 13023226327
hmj@titansci.com China 14098 59
XiaoGan ShenYuan ChemPharm co,ltd 15527621225; 15527621225
1791901229@qq.com China 6722 52
Syntechem Co.,Ltd
info@syntechem.com China 12973 57
Sichuan Kulinan Technology Co., Ltd 400-1166-196 18981987031
cdhxsj@163.com China 11674 57
ShangHai YuanYe Biotechnology Co., Ltd. 18916372613
shyysw007@163.com China 4993 60

55268-75-2()Verwandte Suche:


  • ethyl)-7-((2-furanyl(methyoxyimino)acetyl)amino)-8-oxo-,(6r-(6-alpha,7-beta(z
  • 1-ACETYLOXYETHYL 4-(CARBAMOYLOXYMETHYL)-8-[2-(2-FURYL)-2-METHOXYIMINO-ACETYL]AMINO-7-OXO-2-THIA-6-AZABICYCLO[4.2.0]OCT-4-ENE-5-CARBOXYLATE
  • (6r-(6alpha,7beta(z)))-3-(((aminocarbonyl)oxy)methyl)-7-((2-furanyl(methoxyimino)a cetyl)-amino)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid 1-(acetyloxy)ethyl ester
  • Cefuroxime Axetil EP 8.0 Impurity D
  • cefaloxime
  • -7-((Z)
  • -3-((Carbamoyloxy)
  • -2-(furan-2-yl)
  • 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylicacid,3-[[(aMinocarbonyl)oxy]Methyl]-7-[[(2Z)-2-(2-furanyl)-2-(MethoxyiMino)acetyl]aMino]-8-oxo-,(6R,7R)-
  • (6R,7R)-3-((carbaMoyloxy)Methyl)-7-((Z)-2-(furan-2-yl)-2-(MethoxyiMino)acetaMido)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
  • CefuroxiMe(CefuroxiMe acid)
  • CXM
  • (6R,7R)-3-(Carbamoyloxymethyl)-7-[2-(2-furyl)-2-[(Z)-methoxyimino]acetylamino]-8-oxo-5-thia-1-azabicyclo[4.2.0]octan-2-ene-2-carboxylic acid
  • (6R,7R)-3-[[(Aminocarbonyl)oxy]methyl]-7-[[(2E)-2-(2-furanyl)-2-(methoxyimino)-1-oxoethyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
  • U1troxim
  • Sdectrazole
  • EkLxirrm
  • Biocidin
  • [6R-[6α,7β(Z)]].3-[[(Aminocarbonyl)oxy]methyl]-7-[[2-furanyl(methoxyimino)acetyl]amino]-8-oxo-5-thia-1-azabieyclo[4.2.0]oct-2-ene-2-carboxylic acid
  • Cefuroxime
  • (6r-(6-alpha,7-beta(zethyl)-7-((2- furanyl(methyoxyimino)acetyl)amino)-8-oxo-
  • Ketocef
  • Biofuroksym
  • 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 3-[[(aminocarbonyl)oxy]methyl]-7-[[2-furanyl(methoxyimino)acetyl]amino]-8-oxo-, [6R-[6α,7β(Z)]]-
  • 5-Thia-1-azabicyclo4.2.0oct-2-ene-2-carboxylic acid, 3-(aminocarbonyl)oxymethyl-7-(2Z)-2-furanyl(methoxyimino)acetylamino-8-oxo-, (6R,7R)-
  • Cefuroxime Ester EP Impurity D
  • Cefuroxime USP/EP/BP
  • Pharmacopoeia Standards
  • Cefuroxime acidQ: What is Cefuroxime acid Q: What is the CAS Number of Cefuroxime acid Q: What is the storage condition of Cefuroxime acid
  • (6R,7R)-3-(carbamoyloxymethyl)-7-[[(2Z)-2-(2-furanyl)-2-methoxyimino-1-oxoethyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
  • cefuroxim
  • -8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
  • Cephuroxime
  • Cefuroxime VETRANAL
  • Cefuroxime Axetil EP Impurity D
  • 3-Pyridinepropanoicacid,α-[[(1,6-dimethylethoxy)carbonyl]amino]-,(αS)-
  • Cefuroxime(Cefuroxime Axetil EP Impurity D)
  • Cefuroxime in ACN:H2O (1:1, v/v)
  • Cefuroxime 1000 μg/mL in Acetonitrile
  • (6R,7R)-3-((Carbamoyloxy)methyl)-7-((Z)-2-(furan-2-yl)-2-(methoxyimino)acetamido)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid (Cefuroxime Impurity)
  • Cefuroxime Axetil Impurity 4 (Cefuroxime Axetil EP Impurity D)
  • Cefuroxime acid
  • CEFUROXIME AXETIL
  • (6R,7R)-3-(Aminocarbonyloxymethyl)-7-[2-(2-furyl)-2(Z)-(methoxyimino)acetamido]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
  • 55268-75-2
  • 56238-63-7
  • C16H16N4O8S
  • C20H22N4O10S
  • Antibiotics
  • BacteriostaticAntibiotics
  • beta-Lactam StructureAlphabetic
  • C
  • CA - CG
  • Chemical Structure
  • Principle
Copyright 2019 © ChemicalBook. All rights reserved